These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 37452322)

  • 21. A Novel Immune-Related Gene Signature to Identify the Tumor Microenvironment and Prognose Disease Among Patients With Oral Squamous Cell Carcinoma Patients Using ssGSEA: A Bioinformatics and Biological Validation Study.
    Chen Y; Feng Y; Yan F; Zhao Y; Zhao H; Guo Y
    Front Immunol; 2022; 13():922195. PubMed ID: 35935989
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glycolysis-Related Gene Analyses Indicate That DEPDC1 Promotes the Malignant Progression of Oral Squamous Cell Carcinoma via the WNT/β-Catenin Signaling Pathway.
    Huang G; Chen S; Washio J; Paka Lubamba G; Takahashi N; Li C
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The expression and role of tubulin polymerization-promoting protein 3 in oral squamous cell carcinoma.
    Xiao T; Lin F; Zhou J; Tang Z
    Arch Oral Biol; 2022 Nov; 143():105519. PubMed ID: 36058091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunity-related long noncoding RNA WDFY3-AS2 inhibited cell proliferation and metastasis through Wnt/β-catenin signaling in oral squamous cell carcinoma.
    Lin X; Ding JM; Zheng XZ; Chen JG
    Arch Oral Biol; 2023 Mar; 147():105625. PubMed ID: 36657277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic Cross-Talk between Oral Squamous Cell Carcinoma and Type 2 Diabetes: The Potential Role of Immunity.
    Fan Y; Zhang J; Shi J; Chen L; Long J; Zhang S; Liu S
    Dis Markers; 2022; 2022():6389906. PubMed ID: 35634436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of potential druggable targets of cell cycle with small-molecule inhibitors in oral squamous cell carcinoma.
    Zhou X; Jin W; Chen Y; Zhu L; Mo A; Xie Q
    Pharmacogenet Genomics; 2022 Jun; 32(4):125-137. PubMed ID: 34954767
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NCBP2 and TFRC are novel prognostic biomarkers in oral squamous cell carcinoma.
    Arora R; Haynes L; Kumar M; McNeil R; Ashkani J; Nakoneshny SC; Matthews TW; Chandarana S; Hart RD; Jones SJM; Dort JC; Itani D; Chanda A; Bose P
    Cancer Gene Ther; 2023 May; 30(5):752-765. PubMed ID: 36635327
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreased CSTA expression promotes lymphatic metastasis and predicts poor survival in oral squamous cell carcinoma.
    Wang Y; Wang L; Li X; Qu X; Han N; Ruan M; Zhang C
    Arch Oral Biol; 2021 Jun; 126():105116. PubMed ID: 33831734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of Biological Functions and Prognostic Value of NNMT in Oral Squamous Cell Carcinoma.
    Zhang W; Jing Y; Wang S; Wu Y; Sun Y; Zhuang J; Huang X; Chen S; Zhang X; Song Y; Hu Q; Ni Y
    Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291696
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Upregulation of miRNA-196a and miRNA-196b correlates with Bryne's prognostic score in oral squamous cell carcinoma.
    Singh K; Urs AB; Koner BC; Augustine J; Shrivastava R; Narayan B
    Pathol Res Pract; 2024 Jan; 253():154954. PubMed ID: 38039741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A prognostic model for oral squamous cell carcinoma using 7 genes related to tumor mutational burden.
    Wu F; Du Y; Hou X; Cheng W
    BMC Oral Health; 2022 Apr; 22(1):152. PubMed ID: 35488327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ubiquitination, SUMOylation, and NEDDylation related genes serve as prognostic and therapeutic biomarkers for oral squamous cell carcinoma.
    Deng SZ; Wu X; Kong L; Cheng B; Dai L
    J Oral Pathol Med; 2024 Feb; 53(2):114-123. PubMed ID: 38234119
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Implications of Human Antimicrobial Peptide Defensin Beta-1 in Clinical Oral Squamous Cell Carcinoma Patients via an Integrated Bioinformatics Approach.
    Li S; Li H; Xu Y; Ning W; Hu S; Wei S; Song H; Sun J; Ziebolz D; Schmalz G; Hu X; Liu M
    Comput Math Methods Med; 2022; 2022():2203615. PubMed ID: 35222682
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrated Analysis and MicroRNA Expression Profiling Identified Seven miRNAs Associated With Progression of Oral Squamous Cell Carcinoma.
    Yan ZY; Luo ZQ; Zhang LJ; Li J; Liu JQ
    J Cell Physiol; 2017 Aug; 232(8):2178-2185. PubMed ID: 27935034
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IGF2BP2 maybe a novel prognostic biomarker in oral squamous cell carcinoma.
    Wang X; Xu H; Zhou Z; Guo S; Chen R
    Biosci Rep; 2022 Feb; 42(2):. PubMed ID: 35129592
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-191 regulates oral squamous cell carcinoma cells growth by targeting PLCD1 via the Wnt/β-catenin signaling pathway.
    Wang Z; Guan W; Ma Y; Zhou X; Song G; Wei J; Wang C
    BMC Cancer; 2023 Jul; 23(1):668. PubMed ID: 37460940
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Poor Prognosis of Oral Squamous Cell Carcinoma Correlates With ITGA6.
    Zhang C; Cai Q; Ke J
    Int Dent J; 2023 Apr; 73(2):178-185. PubMed ID: 35820930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deregulation of hsa_circ_0001971/miR-186 and hsa_circ_0001874/miR-296 signaling pathways promotes the proliferation of oral squamous carcinoma cells by synergistically activating SHP2/PLK1 signals.
    Jun W; Shaobo O; Xianhua Z; Siyu Z; Mingyang C; Xin F; Ying C; Lan L
    Sci Rep; 2021 Oct; 11(1):20561. PubMed ID: 34663837
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genome-wide DNA methylation profile identified a unique set of differentially methylated immune genes in oral squamous cell carcinoma patients in India.
    Basu B; Chakraborty J; Chandra A; Katarkar A; Baldevbhai JRK; Dhar Chowdhury D; Ray JG; Chaudhuri K; Chatterjee R
    Clin Epigenetics; 2017; 9():13. PubMed ID: 28174608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genome-wide study of salivary miRNAs identifies miR-423-5p as promising diagnostic and prognostic biomarker in oral squamous cell carcinoma.
    Romani C; Salviato E; Paderno A; Zanotti L; Ravaggi A; Deganello A; Berretti G; Gualtieri T; Marchini S; D'Incalci M; Mattavelli D; Piazza C; Bossi P; Romualdi C; Nicolai P; Bignotti E
    Theranostics; 2021; 11(6):2987-2999. PubMed ID: 33456584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.